ABSTRACT: From 535 endomyocardial biopsies (87 heart transplant recipients) 283 cell cultures could be generated. All cultures tested contained T lymphocyte, and it~ most cases CD4 was the predominant phenotype at any time postrransplant. A significantly higher proportion of CD8-dominated cultures was found among cultureS from biopsies without myocytolysis.
ABSTRACT: From 535 endomyocardial biopsies (87 heart transplant recipients) 283 cell cultures could be generated. All cultures tested contained T lymphocyte, and it~ most cases CD4 was the predominant phenotype at any time postrransplant. A significantly higher proportion of CD8-dominated cultures was found among cultureS from biopsies without myocytolysis.
In the first 3 months post transplant 57% of cultures showed cytotoxicity against both class I and class II mismatched donor major histocorupatibility complex (MHC) antigens, changing to an incidence of 33~ at > 90 day:. This proved to be due to a significant decrease in the number of cultures with human leukocyte antigen class ]]-directed cytotoxicity.
This study shows that early after transplantation a heart transplant is infiItrated with activated donor-specific cytotoxic T cells which recogr.ize a broad spectrum of mismatched donor MHL antigens, and that in time this spectrum becomes more restricted. 
INTRODUCTION
The diagnosis of rejection after clinical heart transplantation is based on histologic criteria [1] . Therefore endomyocardial biopsies (EMB) are taken at regular inter-vals after transplantation. This provides us with the opportunity to culture graft-infiltrating cells which makes it possible to evaluate growth patterns, phenotypic composition, and function of these cells both in periods efgraft stability and during rejection. TEe biopsies were cultured in interleukia-2 (IL-2)-conditioned culture medium in the presence of irradiated autologous peripheral blood mononuclear cells (PBMC) as feeder cells, thereby assuming that only in vivo-acdvated lympkocytes will proliferate [2, 3] . Neither donor nor third-party cells were added within the first 3 weeks of cukure to avoid in vitro activation. In the present re-
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,>3 Americaa Society ft, Histoc<~mpadbii,y and Immun~genetics. i9C)l port, we describe the phenotypic and functional characteristics oflymphocytes grown from EMB, and the relation of these findings with time after transplantation and histopathological diagnosis.
METHODS

Patients.
We studied 535 biopsies from 87 heart transplant recipients transplanted between January 1985 and February 1989. During this transversal study we received 2 to 18 EMB from each patient (median 4). EMB were taken 5 to 1587 days (median 114) after transplantation. All patients had received preoperative blood transfusions and all received cyclosporine and low-dose prednisone only as maintenance immunosuppression. Their actuarial graft survival at 3 years was 89%. Acute rejection episodes, i.e., biopsy-proved myocytolysis, were treated with bolus steroids or with a 2-week course of a polydonal rabbit antithymocym globulin preparation in case of ongoing rejection. In the early posttransplant period serial biopsies were obtained at weekly intervals. Later EMB were taken less frequently, declining to once every 4 months at 1 year. 
Phe~totypic analysis. Surface differentiation antigens
were analyzed by two-color flow cytomerry after sta/ning with monoclonal antibodies directed aga/nst CD3 tanti-leu4) as a pan mature T-tel! marker, w'r31 as a marker for the c~/fl chain of the T-cell receptor ~TCR), and CD8 tanti-leu2) and CD4 (ami-leu3) as T-ceil subset markets. CD16 (anti-leu 1 i) and CD56 (anti-leu 19) were used as markers for natural killer iNK) celas. Antibodies were direcdy conjugated to fluoresceirte (HTC) or phycoerythrin (PE) (Becto~ & Dickinson, Mount~fin View, CA). The presence of r/8 T cells was demonstrated by the monodonM anra-TCR-r/6-1 (clone 11 Cell-mediated cytotoxicity. Cytotoxiciry was tested against donor cells and a panel of unrelated target cells sharing one or more human leukocyte antigens (HLA) with the donor. Fifty-nine bulk cultures could be tested before resrimularion with aIlogeneic cells. The remaining cultures had to be restimulated Jn order to obtain sufficient numbers of cells. No effect of restimulation on cell-mediated lympholysis (CML) specificity could be demonstrated after repeated testing. Three types of target cells were used: PHA-blasts (HLA class I targets), B-LCL (class I and II targets), and the K562 cell line for assessment of NK cell activity. A standard 4-hr 51Cr-release assay was performed [6] with one effecmr-rarget ratio of 20: 1. When possible E:T ratios varying from 1.25 : 1 up to 80 : 1 were used. Target cells were incubated for ! I/2 hr at 37°C with 200 t~Ci 5tCr (Na,CrOt 5 mCi/ml, specific activity 350-600 mCi/mg chromium, Amersham, UK). ~ICr-laheled target cells (2.5 x I0 ~) were mixed with effector cells in 0.2 ml of culture medium in 96-welt roundbottom tissue culture plates. The plates were centrifuged at 600 g for 1 min, incubated at 37°C, and superaatants were collected after 4 hr (Skatron AS, Lier, Norway). Spontaneous chromium release was determined by incubation of targets in 0.2 ml cutture medium, and maximum release was obtained by adding 10% Triton X-lO0 detergent (5% vol/vol solution in 0.01 TRIS buffer) to the targets. Experimental release was measured and specific lysis was calculated with the following equation:
Specific lysis = I00 x Experimental release -spontaneous release Maximum release -spontaneous release A CML assay was considered positive when the percentage specific lysis of donor antigen-bearing target cells exceeded 10% and the slope of a gra1~h was positive [6] . Series of double dilution studies revealed that lysis percentages of less than 10% are within the variation range of the assay (data nor shown).
For statistical analysis of all data a chi-square test, with Yates correction when appropriate, was performed.
RESULTS
Generation of lymphocyte cultures.
In total 283 lymphocyte cultures were established from 535 EMB (53%), From the majority of patients (72/87) cells could be successfully grown from at least one biopsy. From the remaining 15 patients only a few biopsies were available and these were almost always taken more than 1 year after transplantation. Cell growth was most successful from EMB taken in the second and third postoperative months (Table I) . After 3 months a significant decrease of the growth percentage was observed (p q 0.005 when compared to all EMB taken in the first 3 months). Table 2 shows that the rate of establishing ct~ltures is positively correlated with increasing histological rejection grade. Even when no mononuclear cells were detected by histology (grade 0 or 4) cell growth was obtained in 37% of the cas.~.s. These grade 0/4 biopsies showed the highest growth percentages between 11 and 180 days after transplantation with a peak of 64% in the second and third posto-erative months and a decline to 33% after 180 days (p < 0.01 when the pe-lod between I1 and t80 days is compared with > 180 days). EMB showing histological signs of infiltrate (grades 1 and 2) yielded more cultures than grade 0/4 biopsies independent of the time after transplantation. After the first 90 days a decline of the growth rate of grade I EMB was observed (p < 0.01). Grade 2 EMB always showed high growth percentages (Table 2) .
Phenotypicanal~sis. Flow cytometric analysis of cell surface molecules of 200 cultures showed that the majority for HLA A,B and 1.60 versus 1.45 for HLA DR, respectively). In the remaining 1.53 cultures bo~h CD& and CD8 ~ cells were found and the greatest fraction comprised culture7 with CD4 as the predominant phenotype at any time after transplantation. Again, r~o signifieam relation with the number of mismz.zehes w~s fo,md, in the cultures originating from biopsies wL'h myocytolysis the preponderance of CD4 celts w~ more striking and a significantly lower proportion of CDgdominated cultures was found (Fig, 1 , p < 0.025), In 16 cultures from ~3 patients CD3+WT3 l-1 IF2 ÷ cells (TCR r/S*) were found in amounts var;ling from 5% to 100% of the cultured cells (median 27%). The EMB were taken between 29 and 1324 days lposttransplant (median 624 d%,s). In four cases (four different patients) the rS* cells dimly expressed CD8. The remaining cukures only contained CD4-CDS-~'~+ cells. We found ¢8 + cells significandy more often ~t more than 1 year after" transplantation (11/24 versus 5/~.76 phenoryped cultures, p < 0.0Ol). Three of four dimly 
(10 patr:¢'-~tm) CD8* ¢8 ÷ containing cultures originated from EMB taken more than 1 year posttransplant. CD3-ceils were found in 21 cultures (19 patients). In these cultures 7% to 96% of cells expressed CDI6 and/or CD56 antigens (median 24%) and EMB were taken from 6 to I587 days posttransplant (median 148 days). In seven cultures from various patients the NK cells were dimly CD8 positive, six of them were grown from EMB taken in the first posttransplant year. We detected significantly more NK cells in cultures from biopsies taken more than 1 year after transplantation compared to the first posttransplant year (8/24 versus t 3/176, p < 0.001). These cells were never grown from biopsies with myocytolysis.
Call-mediated cytetoxicity. From 126 EMB (47 patients) sufficient cells were generated to test cytotoxic functions (Table 1) . Kilt of donor antigen-bearing target cells was found in t06 cukures. Table 4 shows the results of the specific CML reactivity. Donor-specific cytotoxicity against HLA class I antigens (either alone or in combination with reactivity against class II) was found in 75% of the cases, and against class II antigens (alone or in combination with class I) in 56%. Reactivity against both class I and class II antigens was detected in 48% of the bulk cultures and restricted reactivity (i.e., against either class I or class II antigens only) in 37%. Cultures originating from grades l and 2 EMB showed multisp-r;.]c CML reactivity significantly more often when compared to grade 0 EMB cultures (Table 4 , p < 0.01), while most negative CMLs were found among grade 0 EMB cultures (p < 0.005, compared to grades 1 and 2 EMB cultures). In time a significant shift was observed from a predominantly muhispecific to a more restricted CML pattern when the cultures from EMB taken before and after 3 months were compared (Table 4) . This proved to be due to a significant decrease in the number of cultures with HLA class il-directed cytoroxicity derived from grades 1 and 2 EMB (p < 0.01). This decrease was not accompanied by a significant change in the phenotypic composition of the bulk cultures as CD4 remained the predominant phenotype at any time after transplantation, regardless of the CML specificity of the cultures. Similar phenotypic compositions were found in cultures with HLA class l-directed cytotoxicity and in cultures without donor-directed CML reactivity.
Kill of the K562 cell line was observed in 26/107 tested bulk cultures. In 22 of these allospecific reactivity was also found. NK reactivity did not show a significant relation with time after transplantation or histological rejection grade. Only 7/26 cultures contained cells with the CD16 and/or CD56 phenotype of which two had 70% and 64% CD8 aim* NK cells next to CD4 b~igb:+ T cells. One of the latter cultures showed donor-specific killing next to kill of K562, the other culture did not show donor-specific lysis, but only killed K562. Five of (Table 5) . Cultures from biopsies from nonreiecmrs more ofmn showed a predominance of CD8 ÷ T ceils than EMB cultures from reiectors ~Table 6, p < 0.025). This was due ,o the significandy higher proportion of CDS-dominated cultures derived from histology grade 1 EME in the noareiectors (p < 0.005 compared with grade 1 EMB cukures from rejectors), especially in grade l EblB preceding a grade 0 biopsy. No significant relation wkh time after transplantation could be demonstrated. CML panel reactivity of EMB cultures f~om rejectors changed from a predominantly mukispecific pattern in the first 3 months to a more restricted cytotoxicity thereafter (Table 7 ). In the first 3 months 67% of cultures were cyrotoxic against both HLA class l and class 11, which decreased .'o 36% there=fret (p < 0.01). This was mainly due to a decrease of HLA class II-directed cytotoxicity. In the nonrejectors no significant decline in the fraction of cultures showing multispecific cytotoxicity was found. In the first 3 postoperative months the number of cultures exhibiting cytotoxicity against both HLA class I and lI was lower than in the rejectors. After 3 months no significant difference in cytotoxic specificities between rejectors and nonreiectors could be demonstrated.
DISCUSSION
The present study shows that donor-specific cycotoxic tymphocytes can be grown from EMB taken at any time after transplantation, especially from grades I and 2 EMB. We also showed that CML panel reactivity changed in relation to time from a predominantly multispecific pattern to a more restricted one, which proved to be due to a significant decrease in the number of cultures with HLA class IT-directed cytotoxicity. No corresponding change was observed in the phenotypic composition as CD4 remained the predominant phenotype in most cultures at any time after transplantation. This could mean that only a small fraction of the b'mphocytes in the bulk cultures is responsible for the CML specificity, or that the responsible cytolytic T lymphocytes (CTL) have high affinity antigen receptors that do not require CD4 or CD8 molecules to stabilize antigen binding [7] . MacDonald et al. [8] showed that resistance of routine CTL clones to inhibition with anti-CD8 monoclonal antibodies correlates with in vivo priming 
In the rcj~cror~ a significant declit~e in the number of cuhures with geaeralizccd r¢=~ti~ity was found (32t4~ versus L4/~6, p < 0.OI;*. TMs was rnainIy due to a decrease of HLA dass l]-dieecmd cymtoxidty (34/4fl ar <~J days versus 19/39 at >90 daFs).
In the nonre]ectors this was less apparent.
• ~ = numbers of culture:i, of these cells. Whether T cells carrying high affinity TCR preferentially home in the anograft has not been investigated yet in the human. Another finding in the present study was the h/gher incidence of NK cells and TCR ¢/8 + cells among cultured graft infiltrating cells at 1 year after transplantation which, with one exception for the ~'8 + cells, only originated from EMB without myocytolysis. The role of these cells in an allograft is not clear. They might play a role in maintaining graft stability or just be attracted to the site by lymphokines produced by major histocomparibility complex (MHC)-restricted cells, macrophages, or other types of co|Is. Whether ~rB* cells or NK cells play a role in the development of chronic reiecdon is still under investigation.
Part of the cultures dimly expressed CD8. These CD8 molecules did not seem to function as an accessory molecule mediating class I-directed killing, for none of the bulk cultures containing high percentages of these ceils showed donor-specific tysis. Some of the :,8 ~ cellcontaining cultures were cloned. Neither donor-specific cytotoxicity nor proliferation could be demonstrated in any of the CD8 d~"* or the CD8-,rB" clones [9] . Furthermore, after culture ofCD8 + clones from one biopsy in recombinant IL,2-containing medium the CD8 expression disappeared (data not shown). The CD8 molecule might have been induced on the cells by the culture conditions in medium with a mixture of lymphokines, including 1L-4. It has been demonstrated before that CD8 b*~gh~ can be induced on CD4 + tymphocyces under the influence of IL-4, and that this molecule can be functional in class l-mediated killing [10] .
Several comparative studies of the CD4/CD8 profile of the T cells seen in situ (immunoperoxidase staining) and that of the lymphocyte cultures showed that the CD~/CD8 composition of lymphoid cells cultured from biopsies had a good correlation with the actual situation in the graft [11, 12] . The present study shows that most biopsies yield mixtures of CD4* and CD8-cells with CD4 as the predominant phenotype in most cases, which is in agreement with data of Fung eta/. [13] . [n a limited number of observations others found CD8 as the predominant T-cell subset in cultures from renal or cardiac biopsies. This is thought to be due to the use of azathioprine in their immunosuppressive protocols [2, 12, 14] . Like the present study, no relation between predominant phenotype and the number of HLA mis* matches between donor and recipient was found.
We showed that a lower rejection grade was associated with a higher number of CD8-dominared cultures. Also in patients who never experienced acute rejections, significantly more CD8 + cells were found among infiltrating ceils. These observations could suggest that these cells play a mitigating role in the rejection protess. An alrern~tive explanation for the grea~er pzedo~,.-ination of CD4 ~ cells during reiecrion migh.~ be t~a~. it is a consequence of higher HLA class H expressian on graft tissue. We could not confirm the finding of Weber eta/. [I5] , that cell growth from histo]ogica~y negative EMB obtained in the first ~stoperadve month had a positive correlation with the c~mulative incMenee of subsequent histological rejection.
The lower incidence of HLA cl~ H-directed cytotoxicity after the ~irst 3 months in the present study is in ~reement with an extensive survey ~ong renal transplant recipients [16] . This survey showed that the effect of DR matching on the relarlve risk for graft f~iinre wm high in the first 5 months, thereafter the effect disappeared. On the other hand, the matching effect of HLA class [ antigens was evident during the whole follow-up period. In the present s~udy we showed that class idirected cytotoxiclry remained relar~vely co~szant in time after transplamadon. Several investigators have demonstrated the induction of MHC class i ~ntigens on myocytes and increased expression of cJass I and If on interstitial structures during rejection [17-I9] , which makes the graft tissue more culnerab]e to specific ce]~-mediated lysis [20] . In some studies MHC expression in the atlograft returned to t~ormal after successful rejection treatment [18] , at~hough others found persistence of expression of donor-type c-lass 1I determinants on interstitial structures of the donor heart 1 and 2 years after trmasp]antation [17, 2IJ. It has been shown tha~, to a certain degree, HLA class I1 expressing dendritic cells of donor origin are replaced by recipient bone marrow derived cells [17, 22, 23] . This may contribute to the lower incidence of donor-class H directed cytotoxici~. In vitro experiments have shown that lymphokine~, parficuiarly interferon % regulate the induction and upregulation of(donor) MHC expression on graft tissue and leukocyte binding and penetration through the endothelium [24, 25] , and that ir~ me early posttr~splant period, when the incidence of acute rejection is high, lymphokine-producing ceils are numerous i~ the graft [26] . This is in agreement with our finding that the highest growth rates of aIloacdvaced lymphocytes were found in the second and third months after transplantation. This peak of growth was observed in the rejector as well as nourejector patient groups. Apparently the presence of activated lymphoaytes in the graft does not a/ways lead to Mlograft destruction. We found that ctfllures from nonrejector EMB token in the first 3 postoperative months generatly show a more restricted c~-totoxicity than those from rejectors, which indicates that in this period the number of a[loreactive CTL clones in vivo is lower in nonrejectors. Tl~is might have consequences for the development of myocyte ~njury.
Many speculations h.~ve been made about possible mechanisms involved in stabilization of the graft and on the role different kinds of cells and lymphokines play in this process [27] [28] [29] [30] . Mechanisms that have been proposed to be involved are clonal deletion of antidonor alloreactive cells or specific suppression of aUoreactive T ceils. From earlier studies on circulating mononuclear cells CML hyporesponsiveness [27, 28] and a reduction in the frequency of donor-reactive CTL precursors [29] h~ve been reported in patients with well-functioning geaf~, In contrast, another study on a patient with a wel!-fimctioning kidney graft showed that the frequency of donor-specific CTL precursors was still high, but these cells were not operational in rive [30] . We showed that biopsy-grown lymphocyres from aliografts without acute rejection often still contain donor-directed cytotoxic cells. The mechanism that plays a major role in controlling the immune response in rive is still unclear. Fm'ther investigations will address the question of whether specificity of graft infiltrating cells becomes more restricted because of diminished MHC class I and/or class II expression on donor heart tissue, or if it is caused by deletion or suppression of certain allospecific CTL dories, irrespective of the degree of allograft-MHC expression.
